Cargando…

Microscopic-Observation Drug-Susceptibility Assay for the Diagnosis of Drug-Resistant Tuberculosis in Harare, Zimbabwe

INTRODUCTION: Limited data exist on use of the microscopic-observation drug-susceptibility (MODS) assay among persons suspected of MDR-TB living in high HIV-prevalence settings. METHODS: We retrospectively reviewed available clinical and drug susceptibility data for drug-resistant TB suspects referr...

Descripción completa

Detalles Bibliográficos
Autores principales: Makamure, Beauty, Mhaka, Jesca, Makumbirofa, Salome, Mutetwa, Reggie, Mupfumi, Lucy, Mason, Peter, Metcalfe, John Z.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3569460/
https://www.ncbi.nlm.nih.gov/pubmed/23409072
http://dx.doi.org/10.1371/journal.pone.0055872
_version_ 1782258911737282560
author Makamure, Beauty
Mhaka, Jesca
Makumbirofa, Salome
Mutetwa, Reggie
Mupfumi, Lucy
Mason, Peter
Metcalfe, John Z.
author_facet Makamure, Beauty
Mhaka, Jesca
Makumbirofa, Salome
Mutetwa, Reggie
Mupfumi, Lucy
Mason, Peter
Metcalfe, John Z.
author_sort Makamure, Beauty
collection PubMed
description INTRODUCTION: Limited data exist on use of the microscopic-observation drug-susceptibility (MODS) assay among persons suspected of MDR-TB living in high HIV-prevalence settings. METHODS: We retrospectively reviewed available clinical and drug susceptibility data for drug-resistant TB suspects referred for culture and drug-susceptibility testing between April 1, 2011 and March 1, 2012. The diagnostic accuracy of MODS was estimated against a reference standard including Löwenstein-Jensen (LJ) media and manual liquid (BACTEC MGIT) culture. The accuracy of MODS drug-susceptibility testing (DST) was assessed against a reference standard absolute concentration method. RESULTS: One hundred thirty-eight sputum samples were collected from 99 drug-resistant TB suspects; in addition, six previously cultured MDR isolates were included for assessment of DST accuracy. Among persons with known HIV infection status, 39/59 (66%) were HIV-infected. Eighty-six percent of patients had a history of prior TB treatment, and 80% of individuals were on antituberculous treatment at the time of sample collection. M. tuberculosis was identified by reference standard culture among 34/98 (35%) MDR-TB suspects. Overall MODS sensitivity for M. tuberculosis detection was 85% (95% CI, 69–95%) and specificity was 93% (95% CI, 84–98%); diagnostic accuracy did not significantly differ by HIV infection status. Median time to positivity was significantly shorter for MODS (7 days; IQR 7–15 days) than MGIT (12 days; IQR 6–16 days) or LJ (28 days; IQR 21–35 days; p<0.001). Of 33 specimens with concurrent DST results, sensitivity of the MODS assay for detection of resistance to isoniazid, rifampin, and MDR-TB was 88% (95% CI, 68–97%), 96% (95% CI, 79–100%), and 91% (95% CI, 72–99%), respectively; specificity was 89% (95% CI, 52–100%), 89% (95% CI, 52–100%), and 90% (95% CI, 56–100%), respectively. CONCLUSION: In a high HIV-prevalence setting, MODS diagnosed TB and drug-resistant TB with high sensitivity and shorter turnaround time compared with standard culture and DST methods.
format Online
Article
Text
id pubmed-3569460
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-35694602013-02-13 Microscopic-Observation Drug-Susceptibility Assay for the Diagnosis of Drug-Resistant Tuberculosis in Harare, Zimbabwe Makamure, Beauty Mhaka, Jesca Makumbirofa, Salome Mutetwa, Reggie Mupfumi, Lucy Mason, Peter Metcalfe, John Z. PLoS One Research Article INTRODUCTION: Limited data exist on use of the microscopic-observation drug-susceptibility (MODS) assay among persons suspected of MDR-TB living in high HIV-prevalence settings. METHODS: We retrospectively reviewed available clinical and drug susceptibility data for drug-resistant TB suspects referred for culture and drug-susceptibility testing between April 1, 2011 and March 1, 2012. The diagnostic accuracy of MODS was estimated against a reference standard including Löwenstein-Jensen (LJ) media and manual liquid (BACTEC MGIT) culture. The accuracy of MODS drug-susceptibility testing (DST) was assessed against a reference standard absolute concentration method. RESULTS: One hundred thirty-eight sputum samples were collected from 99 drug-resistant TB suspects; in addition, six previously cultured MDR isolates were included for assessment of DST accuracy. Among persons with known HIV infection status, 39/59 (66%) were HIV-infected. Eighty-six percent of patients had a history of prior TB treatment, and 80% of individuals were on antituberculous treatment at the time of sample collection. M. tuberculosis was identified by reference standard culture among 34/98 (35%) MDR-TB suspects. Overall MODS sensitivity for M. tuberculosis detection was 85% (95% CI, 69–95%) and specificity was 93% (95% CI, 84–98%); diagnostic accuracy did not significantly differ by HIV infection status. Median time to positivity was significantly shorter for MODS (7 days; IQR 7–15 days) than MGIT (12 days; IQR 6–16 days) or LJ (28 days; IQR 21–35 days; p<0.001). Of 33 specimens with concurrent DST results, sensitivity of the MODS assay for detection of resistance to isoniazid, rifampin, and MDR-TB was 88% (95% CI, 68–97%), 96% (95% CI, 79–100%), and 91% (95% CI, 72–99%), respectively; specificity was 89% (95% CI, 52–100%), 89% (95% CI, 52–100%), and 90% (95% CI, 56–100%), respectively. CONCLUSION: In a high HIV-prevalence setting, MODS diagnosed TB and drug-resistant TB with high sensitivity and shorter turnaround time compared with standard culture and DST methods. Public Library of Science 2013-02-11 /pmc/articles/PMC3569460/ /pubmed/23409072 http://dx.doi.org/10.1371/journal.pone.0055872 Text en © 2013 Makamure et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Makamure, Beauty
Mhaka, Jesca
Makumbirofa, Salome
Mutetwa, Reggie
Mupfumi, Lucy
Mason, Peter
Metcalfe, John Z.
Microscopic-Observation Drug-Susceptibility Assay for the Diagnosis of Drug-Resistant Tuberculosis in Harare, Zimbabwe
title Microscopic-Observation Drug-Susceptibility Assay for the Diagnosis of Drug-Resistant Tuberculosis in Harare, Zimbabwe
title_full Microscopic-Observation Drug-Susceptibility Assay for the Diagnosis of Drug-Resistant Tuberculosis in Harare, Zimbabwe
title_fullStr Microscopic-Observation Drug-Susceptibility Assay for the Diagnosis of Drug-Resistant Tuberculosis in Harare, Zimbabwe
title_full_unstemmed Microscopic-Observation Drug-Susceptibility Assay for the Diagnosis of Drug-Resistant Tuberculosis in Harare, Zimbabwe
title_short Microscopic-Observation Drug-Susceptibility Assay for the Diagnosis of Drug-Resistant Tuberculosis in Harare, Zimbabwe
title_sort microscopic-observation drug-susceptibility assay for the diagnosis of drug-resistant tuberculosis in harare, zimbabwe
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3569460/
https://www.ncbi.nlm.nih.gov/pubmed/23409072
http://dx.doi.org/10.1371/journal.pone.0055872
work_keys_str_mv AT makamurebeauty microscopicobservationdrugsusceptibilityassayforthediagnosisofdrugresistanttuberculosisinhararezimbabwe
AT mhakajesca microscopicobservationdrugsusceptibilityassayforthediagnosisofdrugresistanttuberculosisinhararezimbabwe
AT makumbirofasalome microscopicobservationdrugsusceptibilityassayforthediagnosisofdrugresistanttuberculosisinhararezimbabwe
AT mutetwareggie microscopicobservationdrugsusceptibilityassayforthediagnosisofdrugresistanttuberculosisinhararezimbabwe
AT mupfumilucy microscopicobservationdrugsusceptibilityassayforthediagnosisofdrugresistanttuberculosisinhararezimbabwe
AT masonpeter microscopicobservationdrugsusceptibilityassayforthediagnosisofdrugresistanttuberculosisinhararezimbabwe
AT metcalfejohnz microscopicobservationdrugsusceptibilityassayforthediagnosisofdrugresistanttuberculosisinhararezimbabwe